ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyBaselCimeio Therapeutics AG
Cimeio Therapeutics AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Cimeio Therapeutics AG develops immunotherapies paired with genetically modified hematopoietic stem cells for the treatment of hematologic diseases. Its research also targets treatments for autoimmune disorders and genetic diseases.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
✓ Offered3
Shielded-Cell & Immunotherapy Pairs™ (SCIP)
Novel immunotherapies with paired, modified cell-surface protein variants in HSCs; designed to preserve healthy cells while depleting diseased cells and supporting treatment of hematologic diseases.
Cell Shielding
Gene-editing technology that inserts novel protein variants into HSCs or other cells, preserving cell function while making them resistant to depletion by paired immunotherapies.
Therapeutics for hematologic disorders
Development of curative therapies for hematologic disorders, including hematologic malignancies, autoimmune disorders, and genetic diseases, using shielded cells and paired immunotherapies.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Cimeio Therapeutics AG

Trust & reputation

ranQ Trust Score of Cimeio Therapeutics AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

Cimeio Therapeutics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Cimeio Therapeutics AG scores 79.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Cimeio Therapeutics AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Cimeio Therapeutics AG scores 97.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.97.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Cimeio Therapeutics AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Cimeio Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Cimeio Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Cimeio Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Cimeio Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hochbergerstrasse 60f
4057 Basel

At a glance

Legal form
Corporation
UID
CHE-465.367.689
Founded
2020 · 6 years
Last commercial register change
July 29, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
  • Full methodology

    Similar companies

    VA
    Versameb AG
    Basel
    FA
    FimmCyte AG
    Basel
    VA
    Vaximm AG
    Basel
    MS
    Moderna Switzerland GmbH
    Basel
    RG
    RXcel GmbH
    Basel
    RS
    Regeneron Switzerland GmbH
    Basel
    CA
    Celonic AG
    Basel
    BS
    BioNTech Switzerland GmbH
    Basel